These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 10085438)
21. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia. Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470 [TBL] [Abstract][Full Text] [Related]
22. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227 [TBL] [Abstract][Full Text] [Related]
23. Clonality in hematopoietic disorders. Hotta T Int J Hematol; 1997 Dec; 66(4):403-12. PubMed ID: 9479867 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome. Shih LY; Chiu WF; Lee CT Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958 [TBL] [Abstract][Full Text] [Related]
25. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome]. Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301 [TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529 [TBL] [Abstract][Full Text] [Related]
27. [Hematological study in 27 patients with myelodysplastic syndrome (MDS)]. Arai T; Taoka T; Yamaoka G; Kiuchi H; Kawanishi K Rinsho Byori; 1993 Jan; 41(1):107-11. PubMed ID: 8355404 [TBL] [Abstract][Full Text] [Related]
28. Burden of abnormal hematopoietic clone in patients with myelodysplastic syndromes. Wang HQ; Shao ZH; Shi J; Cao YR; Liu H; Bai J; Tu MF; Xing LM; Cui ZZ; Liu SH; Sun J; Jia HR; Yang TY Chin Med Sci J; 2006 Jun; 21(2):99-103. PubMed ID: 16845796 [TBL] [Abstract][Full Text] [Related]
29. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome]. Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097 [TBL] [Abstract][Full Text] [Related]
30. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Yusuf U; Frangoul HA; Gooley TA; Woolfrey AE; Carpenter PA; Andrews RG; Deeg HJ; Appelbaum FR; Anasetti C; Storb R; Sanders JE Bone Marrow Transplant; 2004 Apr; 33(8):805-14. PubMed ID: 14755311 [TBL] [Abstract][Full Text] [Related]
31. [Clonality in refractory anemia]. Ohashi H Rinsho Ketsueki; 1993 Mar; 34(3):265-8. PubMed ID: 8097542 [TBL] [Abstract][Full Text] [Related]
32. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome. Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781 [TBL] [Abstract][Full Text] [Related]
33. Transformation of myelodysplastic syndromes into acute myeloid leukemias. Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365 [TBL] [Abstract][Full Text] [Related]
34. Relapsed myelodysplastic clone differs from acute onset clone as shown by X-linked DNA polymorphism patterns in a patient with acute myeloid leukemia. Jowitt SN; Yin JA; Saunders MJ Blood; 1993 Jul; 82(2):613-8. PubMed ID: 8101105 [TBL] [Abstract][Full Text] [Related]
35. Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessment. Bogdanović AD; Trpinac DP; Janković GM; Bumbasirević VZ; Obradović M; Colović MD Leukemia; 1997 May; 11(5):656-9. PubMed ID: 9180288 [TBL] [Abstract][Full Text] [Related]
36. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Maschek H; Kaloutsi V; Rodriguez-Kaiser M; Werner M; Choritz H; Mainzer K; Dietzfelbinger M; Georgii A Ann Hematol; 1993 Mar; 66(3):117-22. PubMed ID: 8471656 [TBL] [Abstract][Full Text] [Related]
37. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014 [TBL] [Abstract][Full Text] [Related]
38. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome. Yang Y; Zhang Q; Xu F; Chang C; Li X Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040 [TBL] [Abstract][Full Text] [Related]